rs150153477

Variant summary

Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_006772.3(SYNGAP1):​c.1776A>G​(p.Ser592Ser) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0011 in 1,613,806 control chromosomes in the GnomAD database, including 8 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.00096 ( 0 hom., cov: 31)
Exomes 𝑓: 0.0011 ( 8 hom. )

Consequence

SYNGAP1
NM_006772.3 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: -3.41
Variant links:
Genes affected
SYNGAP1 (HGNC:11497): (synaptic Ras GTPase activating protein 1) This gene encodes a Ras GTPase activating protein that is a member of the N-methyl-D-aspartate receptor complex. The N-terminal domain of the protein contains a Ras-GAP domain, a pleckstrin homology domain, and a C2 domain that may be involved in binding of calcium and phospholipids. The C-terminal domain consists of a ten histidine repeat region, serine and tyrosine phosphorylation sites, and a T/SXV motif required for postsynaptic scaffold protein interaction. The encoded protein negatively regulates Ras, Rap and alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor trafficking to the postsynaptic membrane to regulate synaptic plasticity and neuronal homeostasis. Allelic variants of this gene are associated with intellectual disability and autism spectrum disorder. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Nov 2016]
SYNGAP1-AS1 (HGNC:53831): (SYNGAP1 antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BP6
Variant 6-33440828-A-G is Benign according to our data. Variant chr6-33440828-A-G is described in ClinVar as [Likely_benign]. Clinvar id is 240705.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-33440828-A-G is described in Lovd as [Likely_benign].
BP7
Synonymous conserved (PhyloP=-3.41 with no splicing effect.
BS1
Variant frequency is greater than expected in population sas. gnomad4 allele frequency = 0.000961 (146/151926) while in subpopulation SAS AF= 0.00457 (22/4814). AF 95% confidence interval is 0.00309. There are 0 homozygotes in gnomad4. There are 68 alleles in male gnomad4 subpopulation. Median coverage is 31. This position pass quality control queck.
BS2
High AC in GnomAd4 at 146 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SYNGAP1NM_006772.3 linkc.1776A>G p.Ser592Ser synonymous_variant Exon 11 of 19 ENST00000646630.1 NP_006763.2 Q96PV0-1A0A1U9X8L0

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SYNGAP1ENST00000646630.1 linkc.1776A>G p.Ser592Ser synonymous_variant Exon 11 of 19 NM_006772.3 ENSP00000496007.1 Q96PV0-1
SYNGAP1ENST00000644458.1 linkc.1776A>G p.Ser592Ser synonymous_variant Exon 11 of 19 ENSP00000495541.1 A0A2R8Y6T2
SYNGAP1ENST00000449372.7 linkc.1776A>G p.Ser592Ser synonymous_variant Exon 11 of 18 5 ENSP00000416519.4 B7ZCA0
SYNGAP1ENST00000418600.7 linkc.1776A>G p.Ser592Ser synonymous_variant Exon 11 of 19 5 ENSP00000403636.3 Q96PV0-2
SYNGAP1ENST00000645250.1 linkc.1599A>G p.Ser533Ser synonymous_variant Exon 9 of 17 ENSP00000494861.1 A0A2R8YDS2

Frequencies

GnomAD3 genomes
AF:
0.000962
AC:
146
AN:
151808
Hom.:
0
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.000218
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000919
Gnomad ASJ
AF:
0.00403
Gnomad EAS
AF:
0.000386
Gnomad SAS
AF:
0.00457
Gnomad FIN
AF:
0.000190
Gnomad MID
AF:
0.0158
Gnomad NFE
AF:
0.00106
Gnomad OTH
AF:
0.00288
GnomAD3 exomes
AF:
0.00160
AC:
402
AN:
251420
Hom.:
1
AF XY:
0.00191
AC XY:
259
AN XY:
135880
show subpopulations
Gnomad AFR exome
AF:
0.000185
Gnomad AMR exome
AF:
0.00116
Gnomad ASJ exome
AF:
0.00268
Gnomad EAS exome
AF:
0.000109
Gnomad SAS exome
AF:
0.00529
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00135
Gnomad OTH exome
AF:
0.00228
GnomAD4 exome
AF:
0.00111
AC:
1629
AN:
1461880
Hom.:
8
Cov.:
38
AF XY:
0.00125
AC XY:
911
AN XY:
727238
show subpopulations
Gnomad4 AFR exome
AF:
0.000478
Gnomad4 AMR exome
AF:
0.00145
Gnomad4 ASJ exome
AF:
0.00268
Gnomad4 EAS exome
AF:
0.0000504
Gnomad4 SAS exome
AF:
0.00495
Gnomad4 FIN exome
AF:
0.0000562
Gnomad4 NFE exome
AF:
0.000790
Gnomad4 OTH exome
AF:
0.00166
GnomAD4 genome
AF:
0.000961
AC:
146
AN:
151926
Hom.:
0
Cov.:
31
AF XY:
0.000915
AC XY:
68
AN XY:
74280
show subpopulations
Gnomad4 AFR
AF:
0.000217
Gnomad4 AMR
AF:
0.000917
Gnomad4 ASJ
AF:
0.00403
Gnomad4 EAS
AF:
0.000387
Gnomad4 SAS
AF:
0.00457
Gnomad4 FIN
AF:
0.000190
Gnomad4 NFE
AF:
0.00106
Gnomad4 OTH
AF:
0.00285
Alfa
AF:
0.00138
Hom.:
3
Bravo
AF:
0.000948
Asia WGS
AF:
0.00404
AC:
14
AN:
3478
EpiCase
AF:
0.00207
EpiControl
AF:
0.00284

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Feb 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

SYNGAP1: BP4, BP7 -

-
Breakthrough Genomics, Breakthrough Genomics
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: not provided

- -

Aug 28, 2018
GeneDx
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

not specified Benign:2
Sep 27, 2024
Athena Diagnostics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Dec 30, 2016
Genetic Services Laboratory, University of Chicago
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Inborn genetic diseases Benign:1
May 15, 2016
Ambry Genetics
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Intellectual disability, autosomal dominant 5 Benign:1
Jan 30, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

SYNGAP1-related disorder Benign:1
Aug 30, 2021
PreventionGenetics, part of Exact Sciences
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.82
CADD
Benign
7.1
DANN
Benign
0.62
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs150153477; hg19: chr6-33408605; API